Diploma (LON:DPLM – Free Report) had its price objective lifted by JPMorgan Chase & Co. from GBX 5,760 to GBX 8,250 in a report issued on Monday, MarketBeat reports. The firm currently has an overweight rating on the stock.
Several other brokerages have also recently commented on DPLM. Royal Bank Of Canada raised their target price on Diploma from GBX 7,300 to GBX 7,400 and gave the stock an “outperform” rating in a research report on Friday, July 17th. Jefferies Financial Group reissued a “hold” rating and set a GBX 7,000 price target on shares of Diploma in a research report on Friday, May 29th. Berenberg Bank reissued a “buy” rating and issued a GBX 9,000 price objective on shares of Diploma in a research note on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Diploma from GBX 6,400 to GBX 7,200 and gave the stock a “buy” rating in a research note on Wednesday, May 20th. Six equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 7,400.
Get Our Latest Report on Diploma
Diploma Trading Up 1.7%
Insiders Place Their Bets
In related news, insider Mandy Gradden bought 1,000 shares of the business’s stock in a transaction on Friday, July 17th. The stock was bought at an average price of GBX 7,183 per share, for a total transaction of £71,830. Also, insider Katie Bickerstaffe bought 47 shares of the firm’s stock in a transaction on Thursday, July 16th. The shares were bought at an average cost of GBX 7,050 per share, with a total value of £3,313.50. Insiders purchased a total of 1,604 shares of company stock worth $11,447,718 in the last quarter. 1.14% of the stock is currently owned by corporate insiders.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
- Five stocks we like better than Diploma
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
